GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities

GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug ...
RAPS

Long-awaited Cures 2.0 bill unveiled

Two years after beginning work on a follow up to the 21 st Century Cures Act, Reps. Fred Upton (R-MI) and Diana DeGette (D-CO) on Tuesday introduced their Cures 2.0 bill. "Diseases such as cancer, ...
RAPS

Cures 2.0: Discussion draft signals impact on FDA, creation of ARPA-H

More than four years after the 21 st Century Cures Act was signed into law, Reps. Diana DeGette (D-CO) and Fred Upton (R-MI) on Tuesday circulated a discussion draft of their proposed Cures 2.0 ...
JSTOR Daily

Antimicrobial Reimbursement Bill In First Draft Of Cures 2.0

Inside CMS offers exclusive news on the most powerful agency in health care. Publisher Information For over 30 years Inside Washington Publishers has provided exclusive and relevant news about the ...
The New England Journal of Medicine

Interview with Kushal Kadakia on the 21st Century Cures Act, Cures 2.0, and lessons from Covid-19 for medical product development.

Kushal Kadakia is a student at Harvard Medical School with a background in delivery-system reform. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.